Incyte Corporation (INCY) Stock News, Earnings & History

(NASDAQ:INCY) Healthcare

Enjoy Interactive Tools and Indicators

52wk high: 26.30
52wk low: 15.43
EPS: -0.11
P/E: N/A
Div Rate: N/A
Yield: N/A
Market Cap: 3.13B
Avg Vol (3m): 1.31M

Insider Trading Cheat Sheet

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Levy Richard S EVP, Chief Drug Dev&Medical Of May 13 Option Exercise 7.09 60,000 425,400 60,000 May 15 04:17 PM
Levy Richard S EVP, Chief Drug Dev&Medical Of May 13 Sale 22.30 55,699 1,242,088 4,301 May 15 04:17 PM
FRIEDMAN PAUL A Chief Executive Officer May 06 Option Exercise 10.68 23,700 253,088 391,868 May 07 04:40 PM
ARIKO BARRY A Director Apr 05 Option Exercise 4.44 10,000 44,400 45,834 Apr 08 04:04 PM
WHITFIELD ROY A Director Mar 14 Sale 25.08 10,000 250,800 761,082 Mar 18 04:33 PM
WHITFIELD ROY A Director Mar 01 Sale 22.56 10,000 225,600 771,082 Mar 05 04:13 PM
Siegel Eric H. EVP, General Counsel Feb 28 Option Exercise 15.66 50,000 782,910 50,280 Mar 01 04:20 PM
Siegel Eric H. EVP, General Counsel Feb 28 Sale 22.16 50,000 1,108,000 280 Mar 01 04:20 PM
BROOKE PAUL A Director Feb 27 Option Exercise 4.44 10,000 44,400 110,000 Feb 28 04:09 PM
SWAIN PAULA J EVP, Human Resources Feb 20 Option Exercise 6.00 103,283 619,208 121,344 Feb 22 04:06 PM
Yahoo, HV, Market Watch, The Wall St. Journal